1. |
劉江文, 程南生, 潘光棟, 等. PPARγ配體調控人膽囊上皮細胞炎性因子表達的實驗研究 [J] . 中國普外基礎與臨床雜志, 2005; 12(4)∶326.
|
2. |
Li M, Lee TW, Mok TS, et al. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth [J] . J Cell Biochem, 2005; 96(4)∶760.
|
3. |
Valentiner U, Carlsson M, Erttmann R, et al. Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro [J] . Toxicology, 2005; 213(1-2)∶157.
|
4. |
Fenner MH, Elstner E. Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer [J] . Expert Opin Investig Drugs, 2005; 14(6)∶557.
|
5. |
Lu J, Imamura K, Nomura S, et al. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice [J] . Cancer Res, 2005; 65(11)∶4769.
|
6. |
Toyoda M, Takagi H, Horiguchi N, et al. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells [J] . Gut, 2002; 50(4)∶563.
|
7. |
Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer [J] . Science, 1997; 275(5308)∶1943.
|
8. |
Chen WC, Lin MS, Bai X. Induction of apoptosis in colorectal cancer cells by peroxisome proliferators-activated receptor gamma activation up-regulating PTEN and inhibiting PI3K activity [J] . Chin Med J (Engl), 2005; 118(17)∶1477.
|
9. |
Farrow B, Evers BM. Activation of PPARgamma increases PT-EN expression in pancreatic cancer cells [J] . Biochem Biophys Res Commun, 2003; 301(1)∶50.
|
10. |
Patel L, Pass I, Coxon P, et al. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN [J] . Curr Biol, 2001; 11(10)∶764.
|
11. |
Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway [J] . Proc Natl Acad Sci USA, 1999; 96(8)∶4240.
|
12. |
Leslie NR, Downes CP. PTEN: The down side of PI 3-kinase signalling [J] . Cell Signal, 2002; 14(4)∶285.
|
13. |
Stambolic V, Suzuki A, de la Pompa JL, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN [J] . Cell, 1998; 95(1)∶29.
|
14. |
Zhong H, Chiles K, Feldser D, et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics [J] . Cancer Res, 2000; 60(6)∶1541.
|
15. |
Lu Y, Lin YZ, LaPushin R, et al. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells [J] . Oncogene, 1999; 18(50)∶7034.
|